The Centre for MedTech & Innovations (CMTi) is NHG Health’s Innovation and Technology Transfer Office, driving the translation of promising ideas into clinically relevant products and services that address unmet clinical needs. CMTi serves as the catalyst that connects clinical insight with market opportunity—accelerating the development, validation, and adoption of solutions that improve lives.

CMTi plays a pivotal role in strengthening NHG Health’s innovation and enterprise ecosystem through:

Translation of Ideas to Products: Supporting the journey from early-stage research to clinical validation and market readiness through multi-institutional collaborations and robust project execution.
Developing Clinician Innovators and Community: Actively involving clinician innovators and ecosystem stakeholders to build a collaborative culture that emphasizes mentorship, education, and the sharing of expertise and resources.
Introducing technologies into health to improve clinical care through:
- Strategic Partnerships: Engaging with local and international partners across academia, industry, research, and government to foster meaningful collaborations that advance clinical innovation.
- Ecosystem Engagement & Resource Mobilization: Working closely with stakeholders such as NHIC, Enterprise Singapore, start-ups, SMEs, MNCs, and other healthcare clusters to leverage funding and networks essential for scaling MedTech innovation.

CMTi is committed to shaping a connected, resilient, and impact-driven ecosystem—one where innovation is not only translated but also elevated. By empowering clinician innovators and aligning diverse capabilities, CMTi ensures that promising ideas transform into technologies that redefine healthcare across Singapore and beyond.